Dr. Cummings is an Assistant Professor of Radiation Oncology at the University of Rochester School of Medicine and Dentistry and completed graduate studies in Cancer Genetics at Roswell Park in Buffalo, NY and his residency training at the University of Rochester.

My practice specializes in head and neck cancers, prostate cancer including brachytherapy, and bladder cancer. There is often no one best approach for any situation, and the goal of any visit is finding how the uniqueness of each person and their case fits into the published evidence and their own expectations, and setting out a treatment plan that meets those goals.

Outside work I am married with two sons who are young enough to still want to spend time with me, and that keeps me quite busy. I enjoy running outdoors, am a part time Cub Scout Den Leader, skiing in the winter, and watching the Sabres and Bills.

Certified Specialties

Radiation Oncology - American Board of Radiology

Faculty Appointments

Assistant Professor - Department of Radiation Oncology (SMD)

Credentials

Residency & Fellowship

Residency, Radiation Oncology, University of Rochester Medical Center. 2014 - 2018

Internship, Internal Medicine, SUNY Upstate Medical University. 2013 - 2014

Education

MD | SUNY Upstate College of Health Professions. 2013

Awards

Alpha Omega Alpha, Medical Honor Society.

Research

Clinical Trials

Phase III Randomized Trial of Concurrent Chemoradiotherapy with or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer (S1806)

Lead Researcher: Michael Andrew Cummings

This phase III trial studies how well chemotherapy and radiation therapy work with or without atezolizumab in treating patients with localized muscle invasive bladder cancer. Radiation therapy uses high energy rays to kill tumor cells and shrink tumo...

Phase I Trial With Expansion Cohort of DNA-PK Inhibition and IMRT in Cisplatin-Ineligible Patients With Stage 3-4 Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

Lead Researcher: Michael Andrew Cummings

This phase I trial investigates the side effects and best dose of peposertib when given together with radiation therapy in treating patients with head and neck cancer that has spread to other places in the body (advanced) who cannot take cisplatin. P...

Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE)

Lead Researcher: Michael Andrew Cummings

This phase III trial uses the Decipher risk score to guide intensification (for higher Decipher gene risk) or de-intensification (for low Decipher gene risk) of treatment to better match therapies to an individual patient's cancer aggressiveness. The...

Prospective Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck

Lead Researcher: Michael Andrew Cummings

The purpose of this study would like to learn if acupuncture-like electrical therapy can be used in patients with head and neck cancer who have had radiation treatment to treat dry mouth.

Publications

Journal Articles

Influence of air mapping errors on the dosimetric accuracy of prostate CBCT-guided online adaptive radiation therapy.

Lemus OMD, Tanny S, Cummings M, Webster M, Wancura J, Jung H, Zhou Y, Yoon J, Pacella M, Zheng D

Journal of applied clinical medical physics. 2023 June 5 :e14057. Epub 06/05/2023.

Stroke death in patients receiving radiation for head and neck cancer in the modern era.

Hardy SJ, Bandyopadhyay S, Yang H, Williams A, Gudina A, Cummings MA, Zhang H, Singh DP, Chen Y, Mohile NA, Janelsins MC, Milano MT

Frontiers in oncology.. 2023 13 :1111764. Epub 06/15/2023.

Patterns of recurrence after intracranial stereotactic radiosurgery for brain-only metastases from non-small cell lung cancer and the impact of upfront thoracic therapy with synchronous presentation.

Bergsma DP, Moravan MJ, Suri JS, Cummings MA, Usuki KY, Singh DP, Milano MT

Journal of thoracic disease.. 2022 June 14 (6):1869-1879. Epub 1900 01 01.

Squamous cell carcinoma of the head and neck with unknown primary: trends and outcomes from a hospital-based registry.

Cummings MA, Ma SJ, Van Der Sloot P, Milano MT, Singh DP, Singh AK

Annals of translational medicine.. 2021 February 9 (4):284. Epub 1900 01 01.

Long-term maintenance of acinar cells in human submandibular glands after radiation therapy.

Luitje ME; Israel AK; Cummings MA; Giampoli EJ; Allen PD; Newlands SD; Ovitt CE.

International journal of radiation oncology, biology, physics. 2021; 109(4): 1028-1039.

Risk of brain metastases in T1-3N0 NSCLC: a population-based analysis.

Milano MT, Bates JE, Budnik J, Qiu H, Hardy S, Cummings MA, Baumgart MA, Maggiore RJ, Mulford DA, Usuki KY

Lung cancer management.. 2020 February 259 (1):LMT25. Epub 02/25/2020.

Short course radiation therapy for rectal cancer in the elderly: can radical surgery be avoided?

Cummings MA, Usuki KY, Fleming FJ, Tejani MA, Katz AW

Journal of gastrointestinal oncology.. 2019 April 10 (2):357-361. Epub 1900 01 01.

Dosimetric changes achieved and changes in target and parotid volumes in patients undergoing adaptive planning during chemoradiation therapy for squamous cell carcinoma of the head and neck with helical delivery of treatment

Cummings, M; Youn. P; Abu-Aita, R; Herman, A; Hare, M; Zhang, H; Chen, Y; Singh, D.

Journal of Radiotherapy in Practice. 2019; 18(4): 1-7.

Inoperable pulmonary carcinoid tumors: local control rates with stereotactic body radiotherapy/hypofractionated RT with image-guided radiotherapy

Singh D; Chen Y; Cummings MA; Milano MT.

Clin Lung Cancer. 2019; 20(3): e284-e290.

Predicting intracranial progression following stereotactic radiosurgery for brain metastases: Implications for post SRS imaging.

Salama JK, Kirkpatrick JP, Milano MT, Chmura SJ, Adamson J, Fecci PE, Moravan MJ, Choudhury KR, Jutzy JM, Cummings MA, Rushing CN, Natarajan BD

Journal of radiosurgery and SBRT.. 2019 6 (3):179-187. Epub 1900 01 01.

Comparison of Single- and Five-fraction Regimens of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non-small-cell Lung Cancer: A Two-institution Propensity-matched Analysis.

Cummings MA, Ma SJ, Hermann G, Serra L, Syed Y, Malhotra HK, Chen Y, Milano MT, Gomez-Suescun JA, Singh DP, Singh AK

Clinical lung cancer.. 2018 November 19 (6):511-517. Epub 07/30/2018.

Single-Fraction Radiosurgery Using Conservative Doses for Brain Metastases: Durable Responses in Select Primaries With Limited Toxicity.

Cummings M, Youn P, Bergsma DP, Usuki KY, Walter K, Sharma M, Okunieff P, Schell MC, Milano MT

Neurosurgery.. 2018 September 183 (3):437-444. Epub 1900 01 01.

Three- Versus Five-Fraction Regimens of Stereotactic Body Radiotherapy for Peripheral Early-Stage Non-Small-Cell Lung Cancer: A Two-Institution Propensity Score-Matched Analysis.

Ma SJ, Cummings M, Serra LM, Syed YA, Hermann GM, Chen Y, Milano MT, Singh AK, Gomez-Suescun JA, Singh DP

Clinical lung cancer.. 2018 May 19 (3):e297-e302. Epub 11/26/2017.

Severe radiation-induced leukoencephalopathy: Case report and literature review.

Cummings M, Dougherty DW, Mohile NA, Walter KA, Usuki KY, Milano MT

Advances in radiation oncology.. 2016 1 (1):17-20. Epub 02/02/2016.

Dosimetric and clinical analysis of retreatment of vertebral body metastases using intensity modulated radiation therapy.

Chowdhry V, Cummings MA, Hahn SS, Chowdhry AK, Stellingwerf K, Shapiro A

Practical radiation oncology.. 2013 3 (2 Suppl 1):S15-6. Epub 03/25/2013.

Recurrent meningeal sarcoma successfully treated with stereotactic radiosurgery.

Cummings M, Chowdhry V, Shah H, Back J, Kennedy GA

Journal of neurosurgery. Pediatrics.. 2012 November 10 (5):434-8. Epub 09/21/2012.

Ratings & Reviews

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.